Your browser is no longer supported. Please, upgrade your browser.
Settings
FOMX Foamix Pharmaceuticals Ltd. daily Stock Chart
FOMX [NASD]
Foamix Pharmaceuticals Ltd.
Index- P/E- EPS (ttm)-1.30 Insider Own1.00% Shs Outstand61.99M Perf Week-11.11%
Market Cap257.88M Forward P/E- EPS next Y-1.45 Insider Trans-7.58% Shs Float60.88M Perf Month22.35%
Income-71.40M PEG- EPS next Q-0.64 Inst Own51.00% Short Float4.29% Perf Quarter45.96%
Sales1.20M P/S214.90 EPS this Y3.40% Inst Trans-1.09% Short Ratio2.57 Perf Half Y109.05%
Book/sh0.96 P/B4.33 EPS next Y17.60% ROA-81.40% Target Price13.60 Perf Year13.66%
Cash/sh1.21 P/C3.44 EPS next 5Y- ROE-100.60% 52W Range1.97 - 4.84 Perf YTD24.92%
Dividend- P/FCF- EPS past 5Y- ROI-81.50% 52W High-14.05% Beta1.82
Dividend %- Quick Ratio5.70 Sales past 5Y20.70% Gross Margin- 52W Low111.17% ATR0.27
Employees81 Current Ratio5.70 Sales Q/Q- Oper. Margin- RSI (14)58.98 Volatility6.48% 6.74%
OptionableYes Debt/Eq0.24 EPS Q/Q-9.20% Profit Margin- Rel Volume0.49 Prev Close4.24
ShortableYes LT Debt/Eq0.24 EarningsFeb 10 AMC Payout- Avg Volume1.02M Price4.16
Recom1.80 SMA208.36% SMA5020.70% SMA20036.86% Volume503,155 Change-1.89%
Jun-11-19Initiated Barclays Overweight $10
Dec-12-18Initiated BofA/Merrill Buy
Sep-12-18Reiterated H.C. Wainwright Buy $12 → $14
Dec-06-17Initiated Guggenheim Buy $8
Aug-24-17Initiated H.C. Wainwright Buy $12
Feb-15-17Initiated Credit Suisse Outperform $22
Apr-16-15Initiated Guggenheim Buy $14
Mar-16-15Reiterated Barclays Overweight $11 → $15
Nov-18-14Initiated Maxim Group Hold $38
Oct-13-14Initiated Oppenheimer Outperform $15
Jan-22-20 01:00PM  SHAREHOLDER ALERT: Monteverde & Associates PC is Investigating the Following Merger ACCESSWIRE -6.28%
Jan-17-20 08:00AM  Foamix Announces OrbiMeds Support of Merger with Menlo Therapeutics GlobeNewswire
Jan-14-20 08:02AM  Foamix Announces AMZEEQ (minocycline) Achievement of Preferred Status on Express Scripts National Preferred Formulary, One of the Largest Commercial Formularies in the U.S. PR Newswire +8.63%
Jan-09-20 08:01AM  Foamix Announces AMZEEQ (minocycline) Topical Foam Available in Pharmacies Nationwide on January 13th for the Treatment of Moderate to Severe Acne PR Newswire +5.34%
Dec-31-19 11:30PM  Rigrodsky & Long, P.A. Files Class Action Suit Against Foamix Pharmaceuticals Ltd. GlobeNewswire
Dec-13-19 02:44PM  Here is What Hedge Funds Think About Foamix Pharmaceuticals Ltd (FOMX) Insider Monkey
Dec-11-19 08:37PM  Lifshitz & Miller LLP Announces Investigation of Carolina Financial Corporation, Craft Brew Alliance, Inc., Foamix Pharmaceuticals Ltd., Grubhub Inc., Lipocine Inc., Pattern Energy Group, Inc., TD Ameritrade Holding Corporation, and William Lyon Homes PR Newswire
Nov-27-19 11:33AM  Edited Transcript of FOMX earnings conference call or presentation 11-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Nov-26-19 12:15PM  Merger Investigation Alert: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - IPHS, FOMX, RARX ACCESSWIRE
Nov-25-19 06:45PM  SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Foamix Pharmaceuticals Ltd. (Nasdaq - FOMX) ACCESSWIRE
01:30PM  SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Sale of these Companies is Fair to Shareholders - CARO, FIT, FOMX ACCESSWIRE
08:00AM  Foamix Pharmaceuticals to Present at the Piper Jaffray 31st Annual Healthcare Conference GlobeNewswire
Nov-22-19 08:04PM  FOAMIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Foamix Pharmaceuticals Ltd. - FOMX Business Wire
Nov-18-19 08:00AM  Foamix Announces Enrollment Completion of Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam PR Newswire
08:00AM  Foamix Announces Enrollment Completion of Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam GlobeNewswire
Nov-15-19 08:00PM  URGENT NEWS: Monteverde & Associates PC Announces an Investigation of FOAMIX PHARMACEUTICALS LTD - FOMX PR Newswire
Nov-13-19 04:34PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Merger of Menlo Therapeutics Inc. with Foamix Pharmaceuticals Ltd. is Fair to MNLO Shareholders GlobeNewswire
Nov-12-19 05:09PM  SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd. PR Newswire
03:25PM  FOAMIX PHARMACEUTICALS LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Merger ACCESSWIRE
Nov-11-19 11:00PM  MERGER INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - KEM, FOMX, WLH ACCESSWIRE -19.82%
07:09PM  FOAMIX ALERT: Bragar Eagel & Squire, P.C. Investigates Proposed Sale of FOMX and Encourages Investors to Contact the Firm PR Newswire
03:16PM  Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders FOMX, CISN, PEGI, AXE GlobeNewswire
08:00AM  Menlo, Foamix stocks set for selloffs after all-stock merger deal MarketWatch
07:30AM  Foamix (FOMX) Reports Q3 Loss, Misses Revenue Estimates Zacks
06:00AM  Foamix Reports Third Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
06:00AM  Foamix and Menlo Therapeutics to Merge, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications GlobeNewswire
Nov-10-19 04:08PM  The Week Ahead In Biotech: Adcom Test For Amarin's Fish Oil Pill, Agile Awaits FDA Verdict Benzinga
Nov-07-19 08:00AM  Foamix Announces Issuance of New U.S. Patent for Compositions Combining a Retinoid and a Tetracycline Antibiotic GlobeNewswire
Nov-04-19 10:30AM  Will Foamix (FOMX) Report Negative Earnings Next Week? What You Should Know Zacks
08:01AM  Foamix Announces Publication of AMZEEQ (minocycline) Topical Foam Long Term Safety Data for Treatment Up to 1 Year in Journal of Clinical and Aesthetic Dermatology PR Newswire
Nov-01-19 08:00AM  Foamix Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 11 GlobeNewswire +9.97%
Oct-30-19 10:33AM  Will Foamix (FOMX) Report Negative Q3 Earnings? What You Should Know Zacks +6.06%
08:45AM  Have Insiders Been Buying Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) Shares? Simply Wall St.
Oct-23-19 04:24PM  Navigating The Healthcare Industry: Science Fiction Turns to Reality Zacks
08:00AM  Foamix Enters Into Manufacturing and Supply Agreement For AMZEEQ and FMX103 GlobeNewswire
Oct-21-19 08:00AM  Foamix Announces Settlement of Litigation with Teva Relating to Finacea Foam GlobeNewswire
Oct-18-19 04:27PM  Foamix Receives FDA Approval of AMZEEQ Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers PR Newswire
04:07PM  Foamix Receives FDA Approval of AMZEEQ Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers GlobeNewswire
Oct-17-19 11:21AM  Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea PR Newswire
08:00AM  Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea GlobeNewswire
Oct-14-19 12:17AM  3 Top Biotech Stocks With Major Catalysts in October TipRanks
Oct-10-19 08:00AM  Foamix to Present Data on its Topical Product Candidates for Acne, Rosacea at 39th Annual Fall Clinical Dermatology Conference PR Newswire +10.53%
Sep-20-19 05:14PM  Foamix Initiates Phase II Study on Acne Combination Foam Zacks
08:00AM  Foamix Pharmaceuticals to Present at the Cantor Global Healthcare Conference GlobeNewswire
Sep-19-19 08:00AM  Foamix Announces Enrollment of First Patient in Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam GlobeNewswire
Sep-04-19 08:00AM  Foamix Announces Issuance of New U.S. Patent Covering A Method of Treating Acne that Expires in 2037 GlobeNewswire
Aug-16-19 07:15PM  Edited Transcript of FOMX earnings conference call or presentation 8-Aug-19 12:30pm GMT Thomson Reuters StreetEvents +7.27%
Aug-13-19 09:09AM  This Latest Target Price On Foamix (FOMX) Stock Looks Positively Frothy TipRanks +14.93%
Aug-09-19 10:27AM  Bank of America Sees Over 350% Upside in Foamix (FOMX) Stock TipRanks +16.32%
Aug-05-19 08:02AM  Foamix Submits New Drug Application to U.S. FDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular Rosacea PR Newswire
Jul-31-19 10:36AM  Will Foamix (FOMX) Report Negative Earnings Next Week? What You Should Know Zacks
Jul-30-19 08:00AM  Foamix Announces $64 Million Capital Financing Investment by Perceptive Advisors and OrbiMed GlobeNewswire +9.81%
Jul-24-19 08:00AM  Foamix Pharmaceuticals to Report Second Quarter 2019 Financial Results on August 8 GlobeNewswire
Jul-11-19 06:20AM  Do Directors Own Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) Shares? Simply Wall St.
Jun-23-19 04:13PM  Is Foamix Pharmaceuticals Ltd (FOMX) A Good Stock To Buy? Insider Monkey
Jun-12-19 06:29AM  Barclays Has New Plays for Healthcare Fans SmarterAnalyst
Jun-04-19 08:00AM  Foamix Announces Publication of Phase 3 FMX101 Acne Study in Journal of American Academy of Dermatology GlobeNewswire
May-17-19 08:19AM  Edited Transcript of FOMX earnings conference call or presentation 8-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-15-19 06:55AM  Foamix (FOMX): A Beaten-Down Biotech Stock That Looks Like a Bargain Now SmarterAnalyst
May-09-19 03:01PM  Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX): The Best Of Both Worlds Simply Wall St.
11:23AM  Foamix Pharmaceuticals (FOMX) Q1 2019 Earnings Call Transcript Motley Fool
May-07-19 06:05PM  Foamix (FOMX) Reports Q1 Loss, Misses Revenue Estimates Zacks -5.12%
05:03PM  Foamix: 1Q Earnings Snapshot Associated Press
04:21PM  Foamix Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
May-06-19 08:00AM  Foamix Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2019 GlobeNewswire
Apr-30-19 10:32AM  Will Foamix (FOMX) Report Negative Earnings Next Week? What You Should Know Zacks
Apr-29-19 08:00AM  Foamix to Present Late Breaking Data at the 77th Annual Meeting of the Society for Investigative Dermatology GlobeNewswire
Apr-24-19 08:00AM  Foamix Pharmaceuticals First Quarter 2019 Financial Results Conference Call & Webcast Scheduled for May 8 GlobeNewswire
Apr-11-19 12:14PM  This Small-Cap Biotech Stock Could Triple in 2019 GuruFocus.com
Apr-04-19 12:58PM  What Kind Of Share Price Volatility Should You Expect For Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)? Simply Wall St.
Apr-02-19 08:00AM  Foamix Announces Settlement of Litigation with Perrigo Relating to Finacea Foam GlobeNewswire
Mar-08-19 08:00AM  Foamix Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2019 GlobeNewswire +9.00%
Mar-07-19 12:46PM  Edited Transcript of FOMX earnings conference call or presentation 1-Mar-19 1:30pm GMT Thomson Reuters StreetEvents
08:00AM  Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne GlobeNewswire
Mar-06-19 08:00AM  Foamix Pharmaceuticals to Present at the Cowen & Company 39th Annual Health Care Conference GlobeNewswire
Feb-28-19 04:01PM  Foamix Reports Fiscal Year 2018 Financial Results and Provides Corporate Update GlobeNewswire
Feb-27-19 11:50AM  How Many Insiders Bought Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) Shares? Simply Wall St.
08:00AM  Foamix Announces Positive Results from Phase 3 Open-Label Safety Study Evaluating FMX103 Topical Minocycline Foam for Treatment up to One Year GlobeNewswire
Feb-26-19 08:00AM  Foamix -- with Late-Stage Candidates in Acne and Rosacea -- to Participate at American Academy of Dermatology Annual Meeting GlobeNewswire
Feb-21-19 10:31AM  Will Foamix (FOMX) Report Negative Earnings Next Week? What You Should Know Zacks
Feb-14-19 08:00AM  Foamix Pharmaceuticals Fourth Quarter Financial Results Conference Call & Webcast Scheduled for March 1 GlobeNewswire
Jan-23-19 08:00AM  Foamix Announces Appointment of Sharon Barbari to Board of Directors GlobeNewswire
Jan-22-19 11:38AM  Are Foamix Pharmaceuticals Ltd.s (NASDAQ:FOMX) Interest Costs Too High? Simply Wall St.
Dec-21-18 07:00AM  Foamix Submits New Drug Application to U.S. FDA Seeking Approval of FMX101 in Treatment of Moderate-to-Severe Acne GlobeNewswire -6.13%
Dec-16-18 10:16PM  Is Foamix Pharmaceuticals Ltd (FOMX) A Good Stock To Buy? Insider Monkey
Dec-14-18 12:49PM  Could Foamix Pharmaceuticals Ltd.s (NASDAQ:FOMX) Investor Composition Influence The Stock Price? Simply Wall St.
Dec-13-18 02:21AM  Edited Transcript of FOMX earnings conference call or presentation 9-May-18 12:30pm GMT Thomson Reuters StreetEvents
Nov-27-18 08:00AM  Foamix Announces Appointment of Matt Wiley as Chief Commercial Officer GlobeNewswire
Nov-20-18 08:29AM  The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings Benzinga
Nov-19-18 08:00AM  Foamix Announces Appointment of Anthony Bruno to Board of Directors GlobeNewswire -5.63%
Nov-16-18 11:48AM  Edited Transcript of FOMX earnings conference call or presentation 8-Nov-18 1:30pm GMT Thomson Reuters StreetEvents
Nov-13-18 07:55AM  Recent Analysis Shows WPX Energy, Verizon Communications, Innovative Industrial Properties, Foamix Pharmaceuticals, O2Micro International, and Investment Technology Group Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire -6.57%
Nov-07-18 07:50PM  Foamix (FOMX) Reports Q3 Loss, Lags Revenue Estimates Zacks
04:05PM  Foamix Reports Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
06:00AM  Foamix's treatment for common skin condition meets late-stage trial goals Reuters
06:00AM  Foamix Announces Positive Topline Results from Phase 3 Program Evaluating FMX103 Topical Minocycline Foam for Moderate-to-Severe Papulopustular Rosacea GlobeNewswire
Oct-29-18 08:49AM  Implied Volatility Surging for Foamix (FOMX) Stock Options Zacks
08:00AM  Foamix Pharmaceuticals Third Quarter Financial Results Conference Call & Webcast Scheduled for November 8 GlobeNewswire
Oct-22-18 12:26PM  Does Foamix Pharmaceuticals Ltd (NASDAQ:FOMX) Have A High Beta? Simply Wall St.
Oct-12-18 08:00AM  Foamix to Present Clinical Data From Study FX2017-22 at the Fall Clinical Dermatology Conference GlobeNewswire
Foamix Pharmaceuticals Ltd., a late clinical-stage specialty pharmaceutical company, develops and commercializes foam-based formulations for dermatological therapy in the United States, France, Denmark, and Germany. Its lead product candidates include FMX101, a novel topical foam formulation of the antibiotic minocycline that has completed third pivotal Phase III clinical trial for the treatment of moderate-to-severe acne; and FMX103, which is in Phase III clinical trial for the treatment of moderate-to-severe papulopustular rosacea. The company's product pipeline includes FCD105 and FMX109 for the treatment of moderate-to-severe acne vulgaris; and FMX110 for the treatment of papulopustular rosacea. Foamix Pharmaceuticals Ltd. has development and license agreements with Bayer HealthCare AG; LEO Pharma A/S; Mylan N.V.; and Actavis plc. The company was founded in 2003 and is headquartered in Rehovot, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hirsch StanleyDirectorNov 04Option Exercise0.6232,50020,150182,500Nov 05 04:32 PM
Hirsch StanleyDirectorOct 15Option Exercise0.6290,00055,800150,000Oct 17 04:11 PM
Hadar IlanCFO & Country ManagerSep 10Sale3.5034,392120,37589,279Sep 11 05:12 PM
Hadar IlanCFO & Country ManagerSep 09Sale3.509,42032,991123,671Sep 11 05:12 PM
KAZANCHYAN ANNADirectorAug 26Sale3.277,04923,05037,498Aug 28 04:36 PM
Hirsch StanleyDirectorAug 13Option Exercise0.6260,00037,20060,000Aug 14 02:59 PM
KAZANCHYAN ANNADirectorJul 15Sale2.318081,86644,547Jul 17 04:40 PM
Harsch MutyaCLO and General CounselJul 01Sale2.356391,50251,969Jul 03 04:28 PM
Domzalski DavidCEOJul 01Sale2.353,3557,884211,240Jul 03 04:27 PM
Stuart IainChief Scientific OfficerJul 01Sale2.359512,23563,524Jul 03 04:26 PM
KAZANCHYAN ANNADirectorMay 20Sale2.6110,60027,66645,355May 20 06:35 PM
Harsch MutyaCLO and General CounselApr 01Sale3.752,5199,44652,608Apr 03 04:42 PM
Domzalski DavidCEOApr 01Sale3.755,09619,110214,595Apr 03 04:40 PM
Stuart IainChief Scientific OfficerApr 01Sale3.751,6966,36064,475Apr 03 04:38 PM
Wiley Matthew T.Chief Commercial OfficerMar 05Buy3.7613,44050,53463,440Mar 06 04:07 PM